Newsletters

published August 31, 2018
 Today is the start of Lymphoma Awareness Month!Today, 1st September, kicks off our annual Lymphoma Aware
published August 20, 2018
Catch up on the latest Lymphoma Australia news, events and lymphoma updates in our August 2018 e-news edition.
published May 15, 2018
 Lymphoma Australia's newsletter is available here: http://createsend.com/t/d-108BB62B2A880DDC25
published February 7, 2018
Catch up on the latest Lymphoma Australia news, events and lymphoma updates in our February 2018 e-news editio

Contact Lymphoma Australia Today!

Please note:
Lymphoma Australia staff are only able to reply to emails sent in English language.

Newsletter Sign Up

Useful Definitions

  • Refractory: This means the lymphoma does not get better with treatment. The treatment didn’t work as hoped.
  • Relapsed: This means the lymphoma came back after being gone for a while after treatment.
  • 2nd line treatment: This is the second treatment you get if the first one didn’t work (refractory) or if the lymphoma comes back (relapse).
  • 3rd line treatment: This is the third treatment you get if the second one didn’t work or the lymphoma comes back again.
  • Approved: Available in Australia and listed by the Therapeutics Goods Administration (TGA).
  • Funded: Costs are covered for Australian citizens. This means if you have a Medicare card, you shouldn’t have to pay for the treatment.[WO7]

You need healthy T-cells to make CAR T-cells. For this reason, CAR T-cell therapy cannot be used if you have a T-cell lymphoma – yet.

For more information on CAR T-cells and T-cell lymphoma click here. 

Special Note: Although your T-cells are removed from your blood for CAR T-cell therapy, most of our T-cells live outside of our blood – in our lymph nodes, thymus, spleen and other organs.